skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystallization of lysozyme with (R)-, (S)- and (RS)-2-methyl-2, 4-pentanediol

Journal Article · · Acta Crystallographica. Section D: Biological Crystallography
 [1];  [2]; ; ; ;  [1];  [1];  [3];  [1]
  1. Yeshiva University, 2495 Amsterdam Avenue, New York, NY 10033-3312 (United States)
  2. Brookhaven National Laboratory, Building 725D, Upton, NY 11973-5000 (United States)
  3. Collegiate School, 260 West 78th Street, New York, NY 10024-6559 (United States)

Crystallization of lysozyme with (R)-2-methyl-2, 4-pentanediol produces more ordered crystals and a higher resolution protein structure than crystallization with (S)-2-methyl-2, 4-pentanediol. The results suggest that chiral interactions with chiral additives are important in protein crystal formation. Chiral control of crystallization has ample precedent in the small-molecule world, but relatively little is known about the role of chirality in protein crystallization. In this study, lysozyme was crystallized in the presence of the chiral additive 2-methyl-2, 4-pentanediol (MPD) separately using the R and S enantiomers as well as with a racemic RS mixture. Crystals grown with (R)-MPD had the most order and produced the highest resolution protein structures. This result is consistent with the observation that in the crystals grown with (R)-MPD and (RS)-MPD the crystal contacts are made by (R)-MPD, demonstrating that there is preferential interaction between lysozyme and this enantiomer. These findings suggest that chiral interactions are important in protein crystallization.

OSTI ID:
22347717
Journal Information:
Acta Crystallographica. Section D: Biological Crystallography, Vol. 71, Issue Pt 3; Other Information: PMCID: PMC4356360; PMID: 25760593; PUBLISHER-ID: nj5208; OAI: oai:pubmedcentral.nih.gov:4356360; Copyright (c) Stauber et al. 2015; This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0907-4449
Country of Publication:
Denmark
Language:
English

Cited By (1)

An Analysis on Commercial Screening Kits and Chemical Components in Biomacromolecular Crystallization Screening journal August 2019

Similar Records

Crystallization of lysozyme with (R)-, (S)- and (RS)-2-methyl-2,4-pentanediol
Journal Article · Sun Mar 01 00:00:00 EST 2015 · Acta Crystallographica. Section D: Biological Crystallography (Online) · OSTI ID:22347717

Atomic resolution experimental phase information reveals extensive disorder and bound 2-methyl-2,4-pentanediol in Ca 2+ -calmodulin
Journal Article · Fri Jan 01 00:00:00 EST 2016 · Acta Crystallographica. Section D. Structural Biology · OSTI ID:22347717

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative
Journal Article · Mon Jan 01 00:00:00 EST 1990 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:22347717